home

The cost of cancer is predicted to rise by £5.9 billion

 

February 2012

A new report, with research conducted by healthcare analysts, Laing & Buisson, predicts that the cost of cancer diagnosis and treatment will rise from £9.3 billion in 2010 to £15.3 billion by 2021 - an increase of £5.9 billion. Are we heading for a crisis in cancer care?

The increase in the overall cost of cancer diagnosis and treatment is, in part, the result of the UK's ageing population, which is predicted to lead to a 20% growth in cancer rates by 2021. In addition, the report illustrates that the cost of cancer technologies and treatments will continue to rise significantly over the 10 year period.

The report identifies three approaches which could help address the challenge:

Change how and where we treat cancer patients and survivors

Make out-of-hospital care a standard choice for patients when clinically appropriate

Enable patients to manage their follow-up appointment

Find new ways to address the cost of tests and treatments for cancer

Ensure better national planning for availability of new drugs and technologies

Integrate companion tests for personalised medicines into care pathways

Find new ways to bring cancer drugs to market

Make it easier for people to navigate their cancer treatment options

Enable patients to transfer between public and private facilities more easily

 

Click here to download a full copy of the report

Next steps

Contact us

  • Telephone

    Call Bupa Home Healthcare

    01279 456 789